MedPath

Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic Lesions

Not Applicable
Conditions
Pancreatic Cyst
Interventions
Procedure: EUS-FNA
Registration Number
NCT02041897
Lead Sponsor
Xiaoyin Zhang
Brief Summary

It is still controversial about the necessity of endoscopy ultrasound guide fine needle aspiration (EUS-FNA) on diagnosis of pancreatic cystic lesions(PCL).The aim of this study is to find the influence of EUS-FNA on diagnosis and suggestions of EUS specialists.

Detailed Description

First, the investigators will send only EUS images of patients with PCL to diagnosis committee that is consisted with 8 EUS specialists from different countries.The diagnosis will be collected. Then the investigators send the results of EUS-FNA. The diagnosis and suggestions will be collected again. The investigators will calculate how much diagnosis has been changed because of results of EUS-FNA. The investigators will also follow up these patients for 5 years at least to find if these patients benefit from EUS-FNA and complications such as needle tract seeding metastases.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. Adults with ages from 18-80 years old.
  2. The patients with pancreatic cystic lesions, which diameter of cystic lesion more than 2cm.
  3. Sign the informed consent voluntarily. -
Exclusion Criteria
  1. The patient can't accept the endoscopic procedure.

  2. The patient has blood coagulation dysfunction.

  3. The patient has mental disorders.

  4. The patient has mild or severe cardiorespiratory insufficiency.

  5. The patient has hypertension and can't be controlled to safe level.

  6. Patients with alcohol dependence.

  7. Pregnant and lactating women.

  8. The patients the investigators don't think suitable for this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EUS-FNA, Rate of chang on diagnosisEUS-FNAIt is a single arm study. We will conclude by calculating the rate of change of diagnosis before and after getting the results of EUS-FNA.
Primary Outcome Measures
NameTimeMethod
Rate of change of diagnosisDuring 2 weeks

Finish diagnosis before and after getting the results of EUS-FNA

Secondary Outcome Measures
NameTimeMethod
Number of Participants with Adverse Events5 years

after EUS-FNA

Trial Locations

Locations (1)

Department of Gastroenterology,Xijing Hospital

🇨🇳

Xian, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath